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The  earliest  precursor  cell  or  stem  cell  that  populates  the  immunohemopoietic 
system  in  mammals  must  have  a  high  proliferative  potential.  Stem  cells  can  be 
transplanted by intravenous injections of single cell suspensions and can repopulate 
stem cell-depleted recipients  (1,  2).  Therefore, stem cells have been used to test the 
hypothesis that  mammalian aging is  genetically programmed to  cause  loss  of cell 
proliferation in all somatic cells of adults  (3, 4). Yet hemopoietic stem cells from old 
donors  transplanted  into  young  recipients  proliferate  as  well  as  cells  from young 
donors, implying that aging is not an intrinsically timed phenomena (2, 5-11). 
However, after four to six successive serial transplantations,  stem cells lose their 
ability to repopulate and proliferate normally, even if given long periods of time to 
recover after each transplantation (1, 2, 8-15). This loss may result from acceleration 
of the normal aging process, or perhaps from unique stresses caused by transplantation. 
It is important to distinguish between these possibilities: proof that  transplantation 
causes unique stresses would add credibility to the theory that stem cell lines do not 
age. An understanding of how transplantation affects stem cells is also important in 
understanding their functioning, and is of clinical significance as the use of marrow 
transplantation in medicine increases (16,  17). 
Using the technique of competitive repopulation, we have shown that  there is a 
substantial loss of proliferative capacity after a  single marrow transplantation  (10). 
This  loss  is  detected  even when  large  numbers  of marrow cells are  used,  and  the 
interval between transplantations is long (10, 18). Other techniques, such as measuring 
macroscopic spleen colony-forming cell (CFU-S) 1 numbers, detect little or no change 
after a single transplantation under these conditions (1, 2, 5-10,  12). 
Micklem and his colleagues developed the earliest competitive repopulation tech- 
niques  (1).  They transplanted mixtures of genetically distinguishable  (19)  stem cells 
and compared their abilities to repopulate lethally irradiated recipients and maintain 
continuous function for long periods of time. They showed that fetal liver cells were 
better than adult marrow cells (20), cells from the marrow were better than circulating 
cells (21)  and young and old marrow cells functioned identically  (9).  Recently, this 
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group has confirmed our results (10)  showing that  a  single transplantation causes a 
major loss of stem cell-repopulating ability (22). Micklem's studies (9, 20-22) differed 
from  those  reported  here  in  two  ways:  they  compared  stem  cells  from  only  two 
genetically distinguishable donors  at  a  time;  and  specific cell populations were  not 
studied. 
In our studies we needed to simultaneously compare many different donors of the 
same  genotype  to  determine  the  effects  of age  and  transplantation  while  varying 
transplantation procedures. Therefore, in our competitive repopulation assays we mix 
stem  cells from  each  donor with  a  specific dose of genetically distinguishable stem 
cells from  a  single  pool  (10,  18).  Cells from  this  pool  are  called competitors,  and 
several lethally irradiated recipients are given portions of each donor-competitor cell 
mixture.  Cells  from  many  different  donors  are  mixed  with  cells  from  the  same 
competitor pool. Thus the relative repopulating abilities of these donors are simulta- 
neously  determined  by  percentage  of  donor-type  cells  produced  in  each  of  their 
recipients. 
We also needed to compare repopulating abilities of specific erythroid and lymphoid 
cell types. When donor and competitor cells are distinguished by chromosome markers 
(19),  this is done by stimulating proliferation in the cell type desired with a  specific 
stimulus  (10,  18).  When  hemoglobin markers  are used,  the  repopulating ability of 
erythropoietic precursor cells is specifically measured (23). 
To  explore  the  deleterious effect  of transplantation,  we  studied  the  competitive 
repopulating  ability of cells  that  had  been  serially transplanted  using  I05  to  10 s 
marrow cells. The vascular systems of mice were surgically joined so that  stem cells 
would circulate by natural processes from the donor to the lethally irradiated carrier. 
Finally, we  sublethally irradiated  donors  and  allowed  their  stem  cell  numbers  to 
recover without transplantation. 
Materials and  Methods 
Mice.  The following strains of mice were bred and maintained at The Jackson Laboratory, 
Bar  Harbor,  ME:  CBA/HT6  (CBAT6),  CBA/CaJ  (CBA),  and  (CBAT6  X  CBA)F~  mice 
carrying 2, 0, and  1 T(14; 15)6 (hereafter called T6)  chromosome translocations, respectively, 
but otherwise genetically  similar; C57BI/6J (B6) and their F1 hybrids with WB/ReJ (WBB6F1); 
Fl hybrids between B6 and CBAT6  (B6CBAT6F1) or CBA  (B6CBAFI); and  the genetically 
anemic mutants with defective erythropoietic stem cell lines, WBB6F1-W/W". Mice of both 
sexes were used and gave similar results. Male donors were only used with male recipients. 
Irradiation.  Mice were irradiated using either a General Electric Maxitron 250 x-ray machine 
(23) or a  Shepherd Mark I Gamma Irradiator with a  ~37Cs source. Dose rates were 70 or 150 
rad/min,  respectively. All but  the  W/W  v carriers, and  all  recipients used  in  competitive 
repopulation assays, were lethally irradiated 15-18 h before marrow transplantations with 750- 
850  rad  using the  x-ray machine, or with  950-1,100  rad  using the Gamma  Irradiator. To 
perform sublethal irradiation, 550 rad (gamma) was given to CBAT6 donors or 600 R  (x ray) 
was given to B6CBAT6FI donors. 
Marrow Transplantation.  Single cell suspensions of marrow cells were prepared by rinsing 
both femurs and tibias of each donor with Ks-74 medium (24), a balanced salt solution buffered 
with  Hepes  (pH  7.4).  Ceils were counted  (8)  and  stored on  ice until  use.  Recipients were 
injected intravenously with  the appropriate numbers of cells. The  recipients used  for serial 
transplantations are referred to as carriers. 
Competitive Repopulation Assay.  Marrow ceils from each donor were mixed with equal numbers 
of marrow cells from a pool of genetically distinguishable competitors. Mixtures were injected 
intravenously into appropriate recipients. The following assays were performed to determine 
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identified in proliferating cells  using techniques similar to  those of Ford  (19).  To  identify 
specific cell types, erythroid cells in the marrow were stimulated to proliferate by bleeding in 
vivo,  whereas  T  and  B  cells  from  the  spleen  were  stimulated to  proliferate  in  vitro  by 
Ph6Ytohemagglutinin (PHA) and Escherichia coh" lipopolysaccharide (LPS), respectively (10, 18). 
10  spleen cells were cultured in RPMI  1640 medium plus 15% of heat-inactivated fetal calf 
serum (Grand Island Biochemicals, Grand Island, NY), with PHA (HA-17; Burroughs Corp., 
Detroit, MI) at 1.25 #g/1 ml, or with LPS (L2880;  Sigma Chemical Co., St. Louis, MO) at  10 
#g/1 ml. Controls were incubated in mitogen-free medium. 
Erythropoietic stem  cell  proliferation was  analyzed using donors  and  competitors with 
Ot  s  electrophoretically separable hemoglobins (23)• B6 mice have  2,82 hemoglobin, and CBA, 
•  dmaj  CBAT6, and WB mice have az,82  and c~2,82  a  "  hemoglobins. When mixtures of B6  and 
WBB6F1 cells are used in WBB6F1 recipients, or CBAT6 and B6CBAF1 cells in B6CBAT6FI 
recipients, there is little or no hybrid resistance against the parental cells (25), and the amount 
of each hemoglobin type produced is proportional to the number of donor marrow cells of each 
type in the mixture (23). 
Varying Cell Numbers.  To determine whether the transplantation  effect was less when larger 
marrow cell numbers were transplanted, lethally irradiated carriers were given doses of young 
5  8  marrow ranging from 10  to 10 . These cells were allowed to repopulate the carriers for periods 
of time ranging from  13  d  to 4  mo. Thereafter, cells  from each  carrier were  tested  in the 
competitive repopulation assay• The cells were mixed with competitor cells from a single pool, 
and the mixtures were transplanted into lethally irradiated recipients. After periods of time 
ranging from 70 to 211 d, the proportions of donor and competitor cells were determined using 
chromosome or hemoglobin markers as described above. 
Parabiosis.  To  determine whether  the  transplantation effect  is  reduced  when  cells  are 
transplanted by natural processes, lethally irradiated carriers were surgically  joined to donors 
through their vascular systems (25). To test how rapidly blood circulated between the partners, 
S9Fe-labeled erythrocytes were injected in the tail vein of one partner and blood samples were 
removed from each partner's orbital sinus. Previous results showed that mixing was typically 
about one-half  complete after 20 rain in mice that had been in parabiosis successfully for 2-8 
wk. Therefore, circulating  stem cells should have been readily transplanted into the carriers by 
natural processes• These experiments were done in parallel with the transplants in which cell 
numbers were varied. Donors and carriers remained joined for the same periods of time that 
transplanted cells repopulated carriers. 
Sublethal Irradiation.  To study the effects on stem cells of proliferation without transplanta- 
tion, donors were sublethally irradiated with 550-600 rad as previously described. The donors 
were allowed to recover,  and the competitive repopulating ability of their cells was compared 
with the cells of carriers transplanted at the same time. 
UnirradiatedCarrier.  To determine whether the transplantation  effect was caused by irradia- 
tion, unirradiated WBB6F1-W/W  ~ carriers were used. The erythropoietic systems of  IV/W  v 
mice are completely repopulated by transplanted histocompatible normal marrow cells (6). 
Results 
Effects  of Serial  Transplantation  and  Age.  We  confirmed  and  extended  previous 
findings that  stem cells from old and young donors competed equally well against 
genetically distinguishable competitor cells from  the  same pool  (Fig.  1).  However, 
after a  single serial transplantation, the ability of cells from carriers to compete with 
untransplanted competitor cells dropped substantially, regardless of the age  of the 
original donor (Fig.  1). In the competitive repopulation assay for cells responding to 
PHA stimulation, marrow from old donors was >70% as effective as  marrow from 
young donors. After a single serial transplantation in carriers, marrow originally from 
young  donors  was  only  10%,  and  that  from  old  donors  ~20%,  as  effective  as 
untransplanted cells. Thus a  single transplantation caused three  to  seven times as 
great a  deleterious effect as a  lifetime of normal function (Fig.  1). 
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FIG.  I.  Effects of age and  serial transplantation on competitive repopulating ability.  Values in 
parentheses are the number of donors, with 2.3 recipients per donor. Old donors (O) were 24-3 l-too 
old, and young donors (0) were 3  6-too old, CBAT6 mice; this genotype has 2T6 chromosomes. For 
transplantations 2, 3, and 4, their marrow was serially transplanted using 4 X  106  10 ×  106 marrow 
cells per lethally irradiated CBA carrier. These were held 4  12 mo before they were used as donors. 
For competitive repopulation assays, their marrow cells were mixed with young (CBAT6 X CBA)F1 
competitor marrow (3 X  106 cells each) having one T6 chromosome, and intravenously injected in 
lethally irradiated CBA recipients. Recipients were splenectomized to provide spleen cells  for PFIA 
stimulation in vitro, and bled  1 4 wk later to stimulate marrow cells  in vivo.  A mean of 48  (range, 
20  65)  mitoses were scored for each determination after 2-15 too.  Usually, cells  from two old and 
two young donors were studied in each assay;  in  three experiments, donors at  transplantation 2 
were included, and in one experiment, donors at transplantations 3 and 4. Means for all donors are 
plotted; bars give ___ SE. 
declined after long periods of time, we found that  the age of the donor cells did not 
affect  the  ability  to compete.  Results  of several  different  experiments  are  shown  in 
Fig. 2. Stem cells from both old and young donors in each experiment had generally 
consistent  levels of repopulation  over the  following time  periods  (in  days):  11-135, 
60-375, 90-310, and 300-500. Furthermore, old and young donors gave similar results 
in Tables I-III. 
Effects of Transplanting Various Cell Numbers.  In  these  experiments,  carriers  were 
given  105  l0  s  bone  marrow  cells.  After  recovery the  repopulating  cells  from  each 
carrier  were  made  to  compete  against  untransplanted  marrow  cells.  Regardless  of 
whether T  cells, B cells, or erythropoietic cells were studied,  previously transplanted 
cells were  present  at  consistently  lower percentages  than  the  competing cells.  This 
occurred whether carriers  were given  l0  s,  106, or  107 donor marrow cells  (Tables  I 
and  II).  Only  carriers  given  l0  s  cells  performed  substantially  better,  showing  an 
overall average of 28% donor mitoses, midway between the 39-40% of untransplanted 
donors and the  15-18% of carriers given  l0  s to 107 cells (Table I). 
To  claim  that  the  tested  mitotic  cells  are  responding  to  a  specific  stimulus  it  is 
necessary to show that  the stimulus greatly increases the number of cells in mitoses. 
The  numbers  of mitoses  per  1,000  spleen  cells  were  measured  and  the  result  is 
expressed  as  a  percent.  Manifold  increases  were seen  in  cells  exposed  to  PHA and 
LPS, but not after bleeding. PHA and LPS generally caused mitoses to increase 5-20- 
fold  (to  2-5%).  By  comparison,  mitoses  from  marrow  were  usually  only  two-  to 
threefold increased in bled recipients as compared with  untreated recipients.  There- 
fore,  many cells  scored  as  erythropoietic were  multiplying without  the  stimulus  of DAVID  E.  HARRISON AND  CLINTON  M.  ASTLE  1771 
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FIG.  2.  Effects  of time  in  the  recipient  on  the  percentage  of donor cells  in  the  competitive 
repopulation assay. Results using old and young CBAT6 donors are shown in several experiments 
followed for different  periods of time.  Results from recipients given  the  same donor-competitor 
mixtures are joined by lines.  Donor ages (O, old; Q, young) and treatments are the same as in Fig. 
1, transplantation l. 
TABLE  I 
Effect of Transplantation Procedure on Competitive Repopulating Ability 
Transplantation:[:  Percent donor mitoses stimulated by§ 
Donor  Average 
percent- 
age*  Num-  Method  PHA  LPS  Bleeding  age]l 
ber 
0  1  --  34+5  (5)  38+3(5)  48+6(4)  40 
Y  1  --  35+8  (3)  38+_.5  (3)  43+9(3)  39 
O  2  10  7 IV  12 +_. 4  (2)  19 +  4 (3)  14 +  2 (3)  15 
Y  2  105 IV  17+4  (3)  19+_6(4)  10+4(3)  15 
Y  2  106 IV  9+3  (3)  16+4(4)  29+6(4)  18 
Y  2  107 IV  19 +  10 (3)  25 +  6 (3)  9 +  5 (3)  18 
Y  2  l0  s IV  23+_  1  (3)  3l +3(3)  29+ 7 (3)  28 
Y  2  Parabiosis  16 +  3  (7)  17 +- 4 (7)  7 +  2 (7)  13 
Y  1  600rad  12+2  (3)  8+2  (4)  6+2  (4)  9 
* Old (O) and young (Y) B6CBAT6FI donors were 26-28- and 4-6-mo old, respectively. 
Lethally  irradiated  B6CBAF1  carriers  (lines  3-7)  were  given  the  donor marrow cell  numbers listed 
intravenously (IV) and were tested in the competitive repopulation assay at transplantation 2. Carriers 
in line 8 received cells by parabiosis; B6CABT6FI donors in line 9 were irradiated with 600 rad (x ray) 
4 mo before the assay. 
§ In the competitive repopulation assay competitors (pooled marrow from 5-mo olds)  and recipients were 
B6CBAF~ mice, and mixtures of 3 ×  106 donor and competitor marrow cells were given to each recipient 
75-150 d before its cells were stimulated for the assay. Data are given as mean _+ SE. Number of recipients 
is in parentheses; an average of 48 mitoses were scored per recipient. 
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TABLE  II 
Effect of Transplantation Procedure on Competitive  Repopulating Abihty of Erythropoietic Stem Cell Lines 
Donor age* 
Transplantation:~  Percent CBAT6 hemoglobin in recipients 
after§ 
Number  Method  13 d  90 d 
Y  1  --  54 ±  13 (4)  42 ±  4 (4) 
O  2  107i.v.  6±  1  (4)  6+  1 (4) 
Y  2  10Si.v.  5±  1  (4)  -1 +  1 (4) 
Y  2  106i.v.  4±  1  (4)  1 +  l (4) 
Y  2  107i.v.  4±  1  (4)  1 ±  1 (4) 
Y  2  l0  si.v.  8_  1  (4)  14+3  (4) 
Y  2  Parabiosis  2 _+  1  (4)  9 +  2 (4) 
Y  1  550tad  2±  1  (4)  2+  1 (4) 
Y  2  105 i.v. vs. transplant  2  --  1 ±  1 (4) 
Y  2  106 i.v. vs. transplant 2  9 ±  3  (4)  -- 
Y  2  107 i.v. vs. transplant 2  25 ±  5  (4)  21 4- 4 (4) 
* Old (O) and young (Y) CBAT6 donors were 24- and 8-mo old, respectively. 
:~ Lethally  irradiated  B6CBAT6F1  carriers  (lines  2-6)  were  given  donor  marrow  cell  numbers  listed 
intravenously  (i.v.),  and  after  13  and  90  d  were  tested  in  the  competitive repopulation  assay  at 
transplantation 2. Lethally irradiated CBA carriers in line 7 received cells by parabiosis  from the CBAT6 
donors  for 13 and 90 d; CBAT6 donors in line 8 had been irradiated with 550 rad (gamma)  13 and 90 d 
before  the assay.  The  last  three  lines  show  the  same  carriers  as  lines  3-5,  but  are  assayed  against 
competitor cells that had also been previously transplanted  (vs. transplant  2) using 1 ×  10 7 B6CBAF~ 
marrow cells per carrier. 
§ In the competitive repopulation assay, competitors (pooled  marrow from 3.5- and  6.5-mo-old  donors) 
were  B6CBAF1 mice, recipients  were B6CBAT6Fa  mice, and  mixtures of  106  donor  and  competitor 
marrow cells were given to each recipient 70-80 d before its hemoglobin was assayed. Data are given as 
mean +  SE. Number of recipients is in parentheses. 
bleeding. 
It is likely that repopulating abilities of erythropoietic stem cells are measured most 
specifically by using genetically distinguishable  hemoglobins, as in Tables II and  III. 
Marrow  from  carriers  given  105  to  107  donor  cells  showed  no  donor  (CBAT6) 
hemoglobin when  mixed with pooled,  untransplanted  B6CBAF1 marrow  (Table II). 
Repopulating  abilities of marrow  from these carriers were reduced  at least  10-fold in 
13-d, and 20-fold in 90-d, carriers. The hemoglobin assay usually detected a  minimum 
of 2-3%  donor hemoglobin  (23),  but  by  chance  the assay  on  the  13-d carriers could 
not  distinguish  ~5%  donor hemoglobin from 0%.  As found previously, carriers given 
108  cells  did  better:  their  marrow  produced  14%  donor  hemoglobin  after  90  days 
(Table II). This is only one-third of the erythropoietic repopulating ability shown by 
untransplanted  cells, which produced 42% donor hemoglobin after 90 d  (Table II). 
Erythropoietic  function  in  marrow  from carriers  of  10 ~ and  107  CBAT6  cells was 
measured  by  competition  against  B6CBAF1  cells  that  had  also  been  previously 
transplanted  (Table II, bottom 3 lines). Under these conditions, marrow from a  carrier 
given 107 cells produced about  three times as much hemoglobin as that  from a  carrier 
given  106  CBAT6  marrow  cells for  13  d.  Marrow  from  a  carrier  given  l0 b cells still 
failed to produce detectable amounts of hemoglobin. 
Effects of Transplantation  by Parabiosis,  When  the circulatory systems of donor  and 
lethally  irradiated  recipient  are joined,  stem  cells  circulate  and  seed  the  recipient. 
Transplantation  is effected without artificial handling procedures.  Irradiated  carriers DAVID  E.  HARRISON  AND  CLINTON  M.  ASTLE  1773 
that  had  been repopulated by stem cells from parabiotic donors were analyzed by 
competitive repopulation. Marrow cells from such carriers competed poorly. Para- 
biotic carriers gave an overall average for PHA, LPS, and bleeding stimulation of 
13% donor-type mitoses, compared with  15-18% for carriers given 105-107 cells, and 
28% for those given 108 cells (Table I). After 90 d of parabiosis, but not after 13 d of 
parabiosis, parabiotic carriers produced detectable levels (9%)  of hemoglobin when 
competing against  B6CBAF1  marrow.  This  was  fivefold less  than  untransplanted 
donors (Table II). 
Effects of Sublethal Irradiation.  After a  single dose of sublethal  irradiation, mouse 
stem cell numbers (measured as endogenous macroscopic spleen colonies) recover and 
even temporarily exceed original values (27). Therefore, we used sublethal irradiation 
to test the effects of stem cell proliferation. Marrow from sublethally irradiated donors 
performed very poorly in  competitive repopulation assays.  Donors  that  had  been 
sublethally irradiated 4 mo before their marrow was tested produced an average of 
only 9% of their types in assays using chromosome markers (Table 1, bottom line). No 
donor hemoglobin was produced in competitive repopulation assays 13 and 90 d after 
sublethal irradiation (line 8, Table II). 
Use of Unirradiated Carriers.  The very strong deleterious effect of sublethal irradia- 
tion (Tables I and II) suggested that a significant portion of the deleterious effect of 
transplantation may have resulted from using lethally irradiated recipients. Therefore, 
we transplanted marrow cells intravenously from young and old WBB6FI+/+ donors 
into unirradiated WBB6F1-141/W  ~ carriers. Marrow cells were also transplanted by 
parabiosis into  I41/W  ° carriers. In all cases lethally irradiated carriers were used as 
controls. All  I41/W  v carriers were cured of their anemias, showing that their erythro- 
cytic systems were successfully repopulated. Their cells were tested by competitive 
repopulation 111 d after the original transplantation. The stem cells from  I41/W  v or 
lethally irradiated carriers failed to produce detectable amounts of hemoglobin in 
every case (Table III, transplantation 2).  With  minimum detection limits of 2-3%, 
this  was  at  least  a  20-fold  reduction  in  repopulating  ability  compared  with  un- 
transplanted  WBB6FI+/+  stem  cells.  Such  stem  cells  produced  51-57%  of the 
circulating hemoglobin when mixed with the same pool of B6 competitor cells (Table 
III, transplantation  1). As found in the other experiments, there was no deleterious 
effect of donor age, and transplantation by parabiosis did not have a beneficial effect. 
Discussion 
Our  major  finding  is  that  transplantation  is  highly  deleterious to  stem  cell-re- 
populating abilities, especially to erythropoietic stem cells. This effect occurs over a 
wide range of transplanted cell doses and over a variety of transplantation conditions. 
When chromosome markers were used to identify donor cells, a single transplantation 
reduced repopulating abilities by at least three- to sevenfold (Fig.  1). This reduction 
was similar whether thc carrier of the transplanted stem cells received marrow cell 
doses  of  105, 106, or  107;  a  lesser  reduction  was  seen  using  10  s  cells  (Table  I). 
Erythropoietic stem  cell functions were  identified using  hemoglobin markers.  Re- 
populating  abilities  of these  cells  were  reduced  at  least  10-20-fold  by  a  single 
transplantation in carriers that had received 105 to  107 marrow cells 13, 90, and  111 
d before (Tables II and III). They were reduced threefold in carriers that had received 
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TABLE  III 
Effect of Carrier Irradiation and  Transplantation  Procedure on Competitive 
Repopulating  Ability of Erythropoietic Stern Cell Lines 
Transplantation:~ 
Donor  Carrier treat-  Percent WBB6F1 
age*  Num-  Method  ment  hemoglobin§ 
her 
O  1  --  --  57 +  13  (12) 
Y  1  --  --  51 +- 6  (20) 
O  2  10  7 i.v.  W/W  v  -1 -- 1  (12) 
O  2  l0  7 i.v.  Irradiated  -1 +  1  (6) 
Y  2  107 i.v.  W/W"  -2 +  1  (8) 
Y  2  107 i.v.  Irradiated  0 --- 2  (8) 
O  2  10  ~ i.v.  Irradiated  -3 +  0  (8) 
Y  2  10  6 i.v.  Irradiated  -1 +  !  (8) 
Y  2  Parabiosis  W/W  ~  -2 4- 1  (12) 
Y  2  Parabiosis  Irradiated  -2 +  1  (8) 
* Old (O) and young 
respectively. 
(Y) WBB6FI+/+ donors  were 25-28- and 2-8-m0 old, 
:~ Genetically anemic  W/W  v or lethally irradiated normal WBB6FI carriers 
(lines 3  8) were given donor marrow cell numbers listed intravenously (i.v.), 
and after 111  d were tested  in the competitive repopulation assay; this was 
transplantation number 2. 
§ In  the competitive repopulation  assay,  competitors  (pooled  marrow  from 
4  6-mo  old  donors)  were  B6  mice,  recipients  were  WBB6FI  mice,  and 
mixtures of 3 ×  106 donor cells with 7.5 ×  106 competitor marrow cells were 
given to each recipient  113 to 211  d before its hemoglobins were  assayed. 
Data  are  given as  mean  --  SE.  Number  of recipients  is  in  parentheses. 
Negative values result from imprecisions in the hemoglobin assay; B6 donors 
give 0 +  3% WBB6Fj hemoglobin (23). 
Transplantation  by  parabiosis  caused  similar  deleterious  effects as  transplanting 
105-107  marrow  cells  (Tables  I-III).  Apparently,  relocation  of stem  cells,  even  by 
natural  processes, greatly reduces their repopulating ability.  Sublethal  irradiation  of 
the  donor  induces  stern  cell  proliferation,  but  does  not  require  their  relocation. 
However, it affected repopulating abilities even more severely than  transplantation. 
There are several possible explanations for these findings:  (a) The earliest stem cells 
with maximum  functional capacity may be so rare that none are usually found in  107 
marrow  cells,  and  108  cells  must  be  transplanted  to  achieve  a  high  probability  of 
including at least one.  (b)  The deleterious effect may be caused by excessive differen- 
tiation  of stem  cells to  produce  progeny  rather  than  division  to  produce  stem  cells 
shortly after transplantation.  This can be mitigated only by using marrow  cell doses 
approaching  the  total  numbers  of cells in  the  marrow.  The  similarly  high  losses  of 
repopulating ability in carriers of 105-107 marrow cells (Tables I  and  II) suggest that 
the effect is not  simply caused  by  the amount  of proliferation.  (c)  Lethal  irradiation 
may  damage  the  carrier  environment  permanently,  preventing  complete  stem  cell 
regeneration.  (d)  The transplantation  process may physically damage  stem cells. 
Each  of  these  explanations  has  certain  weaknesses.  The  first  suggests  that  107 
marrow cells usually contain none of the earliest stem cells, yet this dose repopulates 
and restores normal functions in genetically anemic and  lethally irradiated recipients 
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retransplanted in successive recipients, and this can be repeated for three to six serial 
transplantations (2, 8). Therefore, doses of 107 marrow cells have a  very substantial 
degree of repopulating ability, although their recipients are defective in competitive 
repopulation assays. 
If the second explanation is true, damage to stem cells would result from excessive 
stimuli to differentiate. However, the deleterious effect of transplantation in unirra- 
diated  W/W  v  recipients (Table III), may be inconsistent with  this  idea.  Levels of 
stimuli  for early precursor cells to differentiate may be greatly reduced in  W/W  v 
compared with lethally irradiated recipients, as the former have normal lymphoid 
cell functions. They live nearly normal life spans, and show normal levels of immune 
competence throughout (28). A dose of 106 IV/W  ~ marrow cells saves and repopulates 
most lethally irradiated recipients (29), and  IV/W ~ mice have 80% of the hematocrits 
and hemoglobin concentrations shown by normal littermates (30). Only if this degree 
of anemia  stimulates  the  excessive differentiation previously discussed  would  the 
second explanation be tenable. 
The deleterious effects of  transplantation in unirradiated W/W  ~ recipients disproves 
the third explanation: that the damage results solely from irradiating the recipients. 
The  fourth possibility seems  unlikely because  of the  effects of two  procedures: 
transplanting by parabiosis and sublethally irradiating the donor. In the former case 
all handling is avoided and cells are transplanted by natural processes; in the latter 
case no transplantation is performed, and stem cells regenerate without any disloca- 
tion. However, both procedures result in severe deleterious effects on stem cell function 
(Tables I-III).  If transplantation  physically damages  cells,  these  procedures must 
cause equivalent amounts of damage. For example, parabiosis may not dislodge the 
earliest  stem  cells,  or  they may  not  be  transplantable  in  the  circulation.  This  is 
suggested by previous findings  (21).  Sublethal  irradiation may permanently injure 
the earliest stem cells. 
Recently,  Micklem  et  al.  (22)  reported  that  long-term  stem  cell-repopulating 
abilities were not  affected by as many as  25  hydroxyurea treatments given over a 
year. Each treatment killed 70% of the CFU-S, as well as higher percentages of more- 
differentiated cells. Deleterious effects may be absent because hydroxyurea treatment 
avoids the disruption of microenviroments caused by transplantation  (22,  31).  Yet 
damage  may  be  caused  without  transplantation.  We  find  that  a  single  dose  of 
sublethal irradiation severely reduces stem cell-repopulating abilities  (Tables I, II). 
Other workers report that  treatments with several other drugs (11, 32, 33), chronic 
damage from 55Fe (34), and repeated treatments with phenylhydrazine (35) all cause 
long-term reductions in CFU-S self-renewal. Possibly, the treatments with sublethal 
irradiation, the other drugs tested, ~SFe, and phenylhydrazine all damage the earliest 
stem cells; hydroxyurea and 5-fluorouracil apparently do not induce this effect (33, 
36, 37). Of course, some of the other treatments may damage the stem cell microen- 
vionment (22, 31) as well as the stem cell. 
Comparing hemoglobin and chromosome markers for donor cells shows an inter- 
esting result. After a single transplantation of ~107 donor marrow cells undetectable 
amounts of donor hemoglobin were produced in competitive repopulation recipients 
(Tables II and III), whereas  10-20% of proliferating cells stimulated by bleeding in 
similar experiments had the donor chromosome marker (Fig. 1, Table I). Thus, using 
hemoglobin to identify donor cells showed much more severely deleterious effects of 1776  LOSS OF  STEM CELL FUNCTION UPON TRANSPLANTATION 
a  single  transplantation  on  erythropoietic stem cell  lines  than  were  detected  using 
chromosome markers. Because chromosomes can only be visualized in  mitotic cells, 
chromosome markers can be scored only in proliferating cells. A significant number 
of marrow cells proliferate in the absence of bleeding, and some of these are probably 
nonerythroid. Thus there may be a set of proliferating cells not as severely affected by 
transplantation as are erythropoietic stem cells.  It is  also possible that  erythrocytes 
produced  by  transplanted  stem  cells  have  a  shorter  life  span  in  the  circulation. 
However, our preliminary results oppose this, because percentages of the two hemo- 
globin  types are similar in  newly synthesized, radiolabeled hemoglobin and  in  the 
hemoglobin of the total erythrocyte population. 
Our comparisons of marrow cells from old and young mice confirm previous reports 
that  they function  equally well when  transplanted  into young recipients  (2,  5-11). 
Reports to the contrary (38-40) may have resulted from the illness of the old donors. 
Because no damage results from a lifetime of normal function, marrow stem cells may 
not age. They are capable of functioning normally for at least five serial transplan- 
tations,  saving lethally irradiated  recipients, or curing genetically anemic recipients 
(1, 2, 8, 9,  12). The deleterious effects of transplantation may result from accelerating 
the mechanisms that cause normal aging, such as exhaustion of limited proliferative 
potential (3, 4). However, a single transplantation causes more damage than 3  7 life 
spans of normal function on PHA-responsive percursor cell lines and  10-20 life spans 
on  erythropoietic  precursor  cell  lines  (Fig.  1;  Tables  I  and  III).  Therefore  these 
precursors appear to have the potential to function for at least  15, and possibly >50 
life spans, because five transplantations are possible. In this case, stem cell lines would 
not age significantly over a normal lifespan. On the other hand, the deleterious effects 
of transplantation may result from causes independent of the aging process. Even in 
this case, the equal functional abilities of stem cells from old and young donors would 
suggest that they do not age. 
Summary 
Long-term functional capacities of marrow cell lines were defined by competitive 
repopulation,  a  technique  capable  of  detecting  a  small  decline  in  repopulating 
abilities. There was little or no difference between cells from old and young donors, 
but  a  single  serial  transplantation  caused  a  large  decline  in  repopulating  ability. 
Varying the numbers of marrow cells transplanted into the initial carrier from 105 to 
107 did not alter the ability of the carrier's marrow cells to repopulate in competition 
with previously untransplanted cells. This ability was improved only in carriers that 
had  received  108  marrow cells,  although  deleterious effects of transplantation  were 
still present. These effects were not solely caused by cell damage from the transplan- 
tation procedure, because transplantation by parabiosis, or recovery from sublethal 
irradiation without transplantation, reduced repopulating abilities as much as trans- 
planting 105 to 107 marrow cells. The transplantation effect also was not caused solely 
by irradiation, because the same effect appeared in unirradiated  W/W  v carriers. 
The transplantation effect was more pronounced when donors were identified by 
hemoglobin type than by chromosome markers, implying that nonerythroid cell lines 
may be  less  affected by  transplantation  than  erythroid  precursor  cells.  When  the 
effects of a  lifetime of normal function and a  single transplantation were compared, 
the latter caused 3-7 times more decline in repopulating abilities of phytohemagglu- DAVID E.  HARRISON  AND CLINTON M.  ASTLE  1777 
tinin-responsive cell precursors, and at  least  10-20 times more decline in erythroid 
cell precursors. Stem cell lines can be serially transplanted at least five times before 
losing their ability to  repopulate and save  lethally irradiated recipients or  to  cure 
genetically anemic mice. Therefore, if transplantation causes an acceleration of the 
normal aging process, these figures suggest that stem cells should be able to function 
normally through at least  15-50 life spans. 
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